ALLO
#2692
Allogene Therapeutics, Inc. - Common Stock
2.0 9 USD
+0.02%
Market Price
Sector: Healthcare
Base: USD
Profit Currency: USD
Daily Range
Year Range
Daily Change
+2.45%
Monthly Change
+20.11%
6 month change
-21.72%
Year Change
+77.12%
Previous Close
2.0 4
Open
2.0 9
Low
2.0 9
High
2.0 9
Volume
91
Financials
- Market Capitalization 722.08 M
- Employee 152
- Founded 2017
- CEO N/A
- Website www.allogene.com
- Headquarter California, United States
- FIGI BBG00KHRRDX3
- Industry Biotechnology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-1.57
Price to sales ratio
—
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 2683 |  BBOT BridgeBio Oncology Therapeutics, Inc. - Common Stock | 9.18 USD | -0.86% | -0.11% | +6.25% | -4.87% | 736.00 M USD | ||
| 2691 |  PHAT Phathom Pharmaceuticals, Inc. - Common Stock | 8.94 USD | +1.94% | +3.59% | -25.00% | -28.25% | 723.25 M USD | ||
| 2699 |  TECX Tectonic Therapeutic, Inc. - Common Stock | 36.70 USD | +2.03% | +0.77% | +23.03% | +113.99% | 717.46 M USD | ||
| 2707 |  ASMB Assembly Biosciences, Inc. - Common Stock | 34.80 USD | -1.75% | +2.78% | +35.15% | +18.27% | 708.55 M USD |
Frequently asked questions about Allogene Therapeutics, Inc. Common Stock
What is the Allogene Therapeutics, Inc. Common Stock stock price today?
The current price of Allogene Therapeutics, Inc. Common Stock (ALLO) is 2.09. Over the past 24 hours, the stock has changed by +2.45%. Follow the ALLO chart for real-time price dynamics.
What is the stock ticker of Allogene Therapeutics, Inc. Common Stock?
Allogene Therapeutics, Inc. Common Stock trades under the ticker ALLO. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is Allogene Therapeutics, Inc. Common Stock stock going up?
ALLO has changed by -1.42% over the last week, +20.11% over the last month, and +77.12% over the last year. Review the chart to see whether the current move is part of a broader trend.
What is the market capitalization of Allogene Therapeutics, Inc. Common Stock?
Allogene Therapeutics, Inc. Common Stock currently has a market capitalization of 722.08 M. Market capitalization reflects the total market value of a company's outstanding shares and is commonly used to compare companies by size.
What were Allogene Therapeutics, Inc. Common Stock earnings last quarter?
Last quarter, Allogene Therapeutics, Inc. Common Stock reported earnings of -0.13 per share. Earnings per share is one of the key metrics investors use to evaluate a company's profitability and financial performance.
What was Allogene Therapeutics, Inc. Common Stock revenue for the last quarter?
Allogene Therapeutics, Inc. Common Stock reported quarterly revenue of 4.64 M. Revenue is one of the main indicators used to evaluate the company's business growth and operating scale.
What was Allogene Therapeutics, Inc. Common Stock net income for the last quarter?
Allogene Therapeutics, Inc. Common Stock reported net income of -42.68 M for the last quarter. The previous quarter showed -42.61 M, which means net income changed by -0.16%.
How many employees does Allogene Therapeutics, Inc. Common Stock have?
As of the latest available data, Allogene Therapeutics, Inc. Common Stock has 152 employees. Workforce size can provide additional context about the company's scale and operations.
What is Allogene Therapeutics, Inc. Common Stock EBITDA?
Allogene Therapeutics, Inc. Common Stock EBITDA is -44.27 M, and its EBITDA margin is -954.2%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.
How can I buy Allogene Therapeutics, Inc. Common Stock stock?
You can buy Allogene Therapeutics, Inc. Common Stock (ALLO) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in Allogene Therapeutics, Inc. Common Stock stock?
Investing in Allogene Therapeutics, Inc. Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the ALLO chart and related analysis on metatrader.com as part of your research.